Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER ; volume:8 ; number:3 ; day:18 ; month:4 ; year:2006 ; pages:1-9 ; date:6.2006
Arthritis Research & Therapy ; 8, Heft 3 (18.4.2006), 1-9, 6.2006
- Urheber
-
Carmona, Loreto
- Beteiligte Personen und Organisationen
-
Gómez-Reino, Juan J.
SpringerLink (Online service)
- DOI
-
10.1186/ar1941
- URN
-
urn:nbn:de:1111-201605034625
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Carmona, Loreto
- Gómez-Reino, Juan J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
04.02 Examination of Effects of TNF-Alpha Antagonists on Arterial Stiffness in Patients with Rheumatoid Arthritis and Related Arthropathies: A Controlled Study
Biosensor-based monitoring of TNF antagonists and anti-drug antibodies in inflammatory bowel disease
Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF
Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn’s Disease (CD)
Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
Leukotriene Receptor Antagonists
The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry
Malignancy validation in a United States registry of rheumatoid arthritis patients
DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
04.02 Examination of Effects of TNF-Alpha Antagonists on Arterial Stiffness in Patients with Rheumatoid Arthritis and Related Arthropathies: A Controlled Study
Biosensor-based monitoring of TNF antagonists and anti-drug antibodies in inflammatory bowel disease
Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF
Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn’s Disease (CD)
Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
Leukotriene Receptor Antagonists
The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry
Malignancy validation in a United States registry of rheumatoid arthritis patients
DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
04.02 Examination of Effects of TNF-Alpha Antagonists on Arterial Stiffness in Patients with Rheumatoid Arthritis and Related Arthropathies: A Controlled Study
Biosensor-based monitoring of TNF antagonists and anti-drug antibodies in inflammatory bowel disease
Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF
Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn’s Disease (CD)
Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
Leukotriene Receptor Antagonists
The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry